Researchers discuss disrupting NKG2A:HLA-E interactions for enhanced anti-cancer immunity
A new editorial titled "Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity" has been published in Oncotarget.
Aug 21, 2024
0
47
MeSH tree: A11.118.637.555.567.537
A new editorial titled "Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity" has been published in Oncotarget.
Aug 21, 2024
0
47
Researchers from University of Queensland's Frazer Institute have discovered the mechanism that bladder cancer uses to suppress the immune system's natural killer (NK) cells.
Aug 20, 2024
0
51
Florida State University researchers are giving oncologists another tool in their fight against pediatric brain cancer.
Aug 12, 2024
0
77
Two studies from Washington University School of Medicine in St. Louis focused on breast cancer and pancreatic cancer suggest that specific types of senescent cells—cells that have stopped dividing and drive inflammation—may ...
Jul 19, 2024
0
99
The protein STAT3 helps the immune system to recognize leukemic cells. This interaction, which is important for future immunotherapies, is now understood in detail thanks to a study at the Karl Landsteiner University of Health ...
Jul 16, 2024
0
31
Researchers at University of California San Diego have found that the most common form of liver cancer—one with a high mortality rate—can be better targeted and treated using an innovative new stem cell-derived therapy, according ...
Jul 9, 2024
0
60
Periods of fasting reprogram the immune system's natural killer cells to better fight cancer, according to a new study in mice from researchers at Memorial Sloan Kettering Cancer Center (MSK).
Jun 14, 2024
1
131
Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukemia, new research has shown.
May 21, 2024
0
48
Cancer has a profound impact on human life, and immune checkpoint therapy (ICT) has made remarkable strides in cancer treatment. However, ICT faces challenges such as low overall response rates and the emergence of immune-related ...
May 9, 2024
0
32
Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune system. In this way, the body presumably curbs destructive immune reactions.
May 3, 2024
0
65